Back to discover
Disease

Critical Illness

Late-stage therapeutic developmentEmerging researchCooling momentum
17
Publications
22
Clinical trials
6
Related conditions
4
Related proteins
2025
Latest publication
Current focus
Antibodies biologyImmunoglobulin g biologyTherapeutic developmentInflammation & immunityMetabolic & lifestyle factors
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

Acute kidney injury.

Research2021-07-15Nature reviews. Disease primers

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Clinical trials

16 sponsors · 2 new · 1 completed in the last 12 months (net +2)

The current development programme across all trial phases.

Clinical programme
22
All trials
6
Active
18
Late-stage
6
Completed
Late-stage studies
Recruiting
Recently completed

Research activity

17 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20142025
Major themes8
  • Critical Illness6
  • COVID-193
  • Gastrointestinal Microbiome2
  • Host-Pathogen Interactions2
  • Acute Kidney Injury1
  • Amino Acids1
  • Attitude of Health Personnel1
  • Betacoronavirus1
Leading journals6
  • Nature3
  • Science (New York, N.Y.)2
  • Allergy1
  • Blood advances1
  • BMC gastroenterology1
  • Diabetes/metabolism research and reviews1
Leading researchers8
  • Abel L2
  • Aiuti A2
  • Baillie JK2
  • Bastard P2
  • Beaussant Y2
  • Belot A2
  • Béziat V2
  • Bilguvar K2
Affiliations (unnormalised)6
  • Karolinska Institutet3
  • School of Life Sciences3
  • William Harvey Research Institute3
  • Aarhus University2
  • Aarhus University Hospital2
  • Avicenne Hospital2

Disease biology

4 matches

Key proteins & gene products studied in this disease. Number shows shared papers.

Related conditions

6 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Critical illness is a disease or state in which death is possible or imminent. The supplied literature frames it as a severe clinical state associated with high mortality and the need for intensive management, often discussed in the context of severe infections and organ dysfunction.

Causes

The grounding does not support a single cause for critical illness as a general state. It is discussed in association with severe infections, sepsis, trauma-related illness, hypovolaemic shock, and severe COVID-19, but these are examples of conditions linked to critical deterioration rather than a complete aetiology.

Pathophysiology

The supplied material does not define a single unified mechanism for critical illness. It points to diverse pathophysiological processes depending on the underlying condition, including impaired intestinal barrier function and permeability, host-pathogen interactions, immune dysregulation, acute kidney injury, coagulation disorders, thromboembolism, and abnormal type I interferon responses in severe viral disease.

Risk factors

Risk factors are supported mainly in the context of progression to severe or critical COVID-19. These include old age, male sex, obesity, diabetes, hypertension, chronic lung disease, heart, liver and kidney disease, tumors, clinically apparent immunodeficiencies, local immunodeficiencies such as reduced early type I interferon secretion capacity, and pregnancy.

Current standard of care

The grounding supports intensive supportive and disease-directed therapy at the level of broad modality rather than specific regimens. It also indicates management of associated complications such as acute kidney injury, coagulation disorders, and thromboembolism, with treatment approaches varying by the underlying cause and severity of illness.

AI-generated summary grounded in MeSH and 6 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A disease or state in which death is possible or imminent.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.